The NSW government’s $16.6 million RSV prevention program will cover the cost of nirsevimab (Beyfortus), a monoclonal ...
Public health experts are warning that the rising rates of RSV in the Southern U.S. could be a sign we need to prepare here in Southern California At one hospital in Texas, doctors are sounding the ...
The RSV prevention program will see the NSW Government fund nirsevimab, a type of monoclonal antibody immunisation, from mid-March for babies who are not protected through maternal vaccination, and ...